Moderate riskFDA DrugClass II

Inventia chlorthalidone tablets recalled for failed dissolution

Inventia Healthcare Limited's chlorthalidone 25 mg tablets (batch RISA24002, expiring 04/2027) failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could affect how well the medication works. About 13,567 bottles were distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have chlorthalidone from Inventia Healthcare with batch number RISA24002
  2. Contact your pharmacy or doctor if you have this medication
  3. Do not stop taking your blood pressure medication without talking to your doctor first

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
13567 bottles
Illnesses reported
None reported
Manufactured in
Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, Kalyan, N/A, India
Classification
Class II
Recall number
D-0852-2026

In the FDA's words

Description
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 Failed Dissolution Specifications Batch # RISA24002; Exp Date: 04/2027 Distribution: U.S. Nationwide Affected quantity: 13567 bottles
Hazard
Failed Dissolution Specifications

Related topics

PotencyDrugsSold nationwideMore from FDA Drug